🔎 Trials Near Me

Home › Kanser sa Prostate › North Carolina

Pag-aaral pangklinika para sa Kanser sa Prostate sa North Carolina

47 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Duke University, Durham
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Durham VA Medical Center, Durham
  • Duke University Medical Center, Durham
  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 2, 2026 · NCT06931340

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Novant Health Cancer Institute - Kernersville, Kernersville
  • Novant Health Cancer Institute - Mount Airy, Mount Airy
  • Novant Health Forsyth Medical Center, Winston-Salem
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AdventHealth Infusion Center Asheville, Asheville
  • Southeastern Medical Oncology Center-Clinton, Clinton
  • AdventHealth Infusion Center Haywood, Clyde
  • at 6 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Margaret R Pardee Memorial Hospital, Hendersonville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • Atrium Health Levine Cancer Institute, Charlotte
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Set 28, 2026 · NCT06095089

DESTINY-PANTUMOUR04

  • Research Site, Durham
  • Research Site, Wilson
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Duke University Medical Center, Durham
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT06800313

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • Duke Cancer Center Cary, Cary
  • Duke University Medical Center (location of scans), Durham
  • Duke University Medical Center - Duke Cancer Center, Durham
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 24, 2026 · NCT07028853

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Durham VA Medical Center, Durham, NC, Durham
  • Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Durham VA Medical Center, Durham, NC, Durham
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT04038502

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

  • Duke University Medical Center, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Set 15, 2026 · NCT07493512

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Associated Urologists of North Carolina (AUNC), Raleigh
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Set 14, 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Duke University Medical Center, Durham
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Durham VA Medical Center, Durham
  • CarolinaEast Medical Center, New Bern
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 10, 2026 · NCT05946213

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

  • Urology Specialists of the Carolinas - University Place, Charlotte
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 3, 2026 · NCT07723248

The Vanguard Study: Testing a New Way to Screen for Cancer

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Durham VA Medical Center, Durham
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06995898

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

  • Duke University, Durham
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kalalakihan · Na-update Ago 27, 2026 · NCT07050433

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Levine Cancer Institute, Charlotte
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 24, 2026 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Duke University Medical Center, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Ago 21, 2026 · NCT04221542

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • Duke University medical center, Durham
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Ago 20, 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • ECU Health Oncology Kinston, Kinston
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Ago 19, 2026 · NCT04423211

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • Duke University Medical Center - Duke Cancer Center, Durham
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 17, 2026 · NCT06842498

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Duke University, Durham
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  • Duke Cancer Institute, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Ago 10, 2026 · NCT06067841

A Study of DM002 in Patients With Advanced Solid Tumors

  • Carolina BioOncology Institute, LLC, Huntersville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06751329

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

  • Duke University, Durham
Nagre-recruitObservasyonal na pag-aaral
Edad 40 pataas · Kalalakihan · Na-update Ago 6, 2026 · NCT07144228

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Atrium Health University City/LCI-University, Charlotte
  • Levine Cancer Institute-Ballantyne, Charlotte
  • at 9 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

  • Wake Forest University Health Sciences, Winston-Salem
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT05691465

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Duke Cancer Center, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Hul 9, 2026 · NCT07103018

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Levine Cancer Institute, Charlotte
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Hul 9, 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

  • Cape Fear Valley Health System, Fayetteville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  • Duke University, Durham
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Hun 25, 2026 · NCT06457919

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07463833

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

  • W.G. Bill Hefner Medical Center, Salisbury
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Hun 15, 2026 · NCT05422911

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • Duke University Medical Center, Durham
Nagre-recruitPhase 4
Edad 18 hanggang 100 · Kalalakihan · Na-update Hun 4, 2026 · NCT05803941

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Durham VA Medical Center, Durham
  • Duke Cancer Network, Durham
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Kalalakihan · Na-update May 22, 2026 · NCT03151629

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

  • W.G. Bill Hefner VA Medical Center, Salisbury
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Abr 13, 2026 · NCT04337580

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • Durham VA Medical Center, Durham, NC, Durham
Nagre-recruitPhase 2/3
Edad 18 pataas · Kalalakihan · Na-update Abr 8, 2026 · NCT04787744

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.